The Discounted Cash Flow (DCF) valuation of Collegium Pharmaceutical Inc (COLL) is 39.49 USD. With the latest stock price at 36.16 USD, the upside of Collegium Pharmaceutical Inc based on DCF is 9.2%.
Based on the latest price of 36.16 USD and our DCF valuation, Collegium Pharmaceutical Inc (COLL) is a buy. buying COLL stocks now will result in a potential gain of 9.2%.
| Range | Selected | |
| WACC / Discount Rate | 6.7% - 8.4% | 7.6% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | 19.18 - 101.64 | 39.49 |
| Upside | -47.0% - 181.1% | 9.2% |